Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report
Obstetrics & Gynecology Science
;
: 69-72, 2019.
Artículo
en Inglés
| WPRIM
| ID: wpr-719670
ABSTRACT
Posterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot GnRH agonists in a 44-year-old woman with a huge myoma uteri and iron-deficiency anemia. Brain magnetic resonance imaging showed high signal lesions in both occipital lobes on fluid-attenuated inversion-recovery (FLAIR) images, compatible with PRES. After treatment with anticonvulsant, she recovered both radiographically and clinically. The association between PRES and GnRH agonist use is still enigmatic, and thus should be further clarified.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Útero
/
Encéfalo
/
Encefalopatías
/
Imagen por Resonancia Magnética
/
Hormona Liberadora de Gonadotropina
/
Leuprolida
/
Anemia Ferropénica
/
Síndrome de Leucoencefalopatía Posterior
/
Mioma
/
Lóbulo Occipital
Límite:
Adulto
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Obstetrics & Gynecology Science
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS